Home › Therapeutic areas › Dermatology › Psoriasis

Psoriasis (8 companies)

Companies with an active program in Psoriasis.

Ticker Company Therapeutic areas Programs Lead stage Mkt cap Programs
AARD Aardvark Therapeutics DermatologyMetabolic+1 Rare 1 Phase 3 $25.2M 3
ALMS Alumis DermatologyImmunology+1 1 Phase 3 $628M 5
ANAB AnaptysBio DermatologyGI/Hepatology+2 Rare 1 Approved $1.36B 9
ORKA Oruka Therapeutics DermatologyImmunology Rare 3 Phase 2 $6.53B 7
PTGX Protagonist Therapeutics DermatologyHematology+2 Rare 2 Approved $8.14B 12
RVPH Reviva Pharmaceuticals CardiovascularDermatology+3 Rare 1 Phase 3 $4.7M 11
VNDA Vanda Pharmaceuticals CardiovascularDermatology+6 Rare 2 Approved $230M 27
ZBIO Zenas BioPharma DermatologyImmunology+2 Rare 1 NDA Submitted $1.88B 11